Summit Communications, LLC

Summit Communications is a medical education publisher that develops timely, evidence-based, and clinically focused monographs. These monographs generally take the form of small guidebooks for medical professionals that provide basic scientific background but emphasize the clinical applications of a particular disorder and/or treatment with extensive practical data and visual examples. The development and distribution for each Summit monograph is supported by educational grants, which are secured prior to product development.

Clinicians and various medical professionals read Summit monographs because they are authored by leading key opinion leaders in their related fields. Addressing the most compelling clinical topics for efficient reference, each Summit monograph is developed with objectivity and thoroughness, along with appropriate academic support. In order for distribution and referencing to be a widespread as possible, Summit monographs are provided gratis to the most active practitioners working in the topic, or sold affordably through the international book trade.

Summit’s model of developing timely and compelling clinical monographs, while securing grants up-front, achieves wide dissemination of the content, and allows grantors to support current, accurate, and objective information flow. This type of publishing has proven particularly effective for grantors in light of the many regulatory restrictions related to pharmaceutical education and promotion over the last five years, particularly in the United States.

Past grantors include:

• Novartis
• GlaxoSmithKline
• Genentech
• Ortho Biotech
• Encysive Pharmaceuticals
• Amgen
• Abbott Spine
• Alphatec